Deep Breathe is a London, Ontario medical-technology company developing locally run artificial-intelligence tools that use ultrasound to assist point-of-care diagnosis of serious lung and torso conditions.
Operating context
Deep Breathe develops ATLAS for AI-assisted ultrasound assessment of critical torso injuries, with locally running iOS/Android software intended for disconnected environments. Its FAQ identifies ATLASim as available for education and training and says broader ATLAS regulatory approvals are being pursued. The separately cleared BlineSlide device has a narrower documented scope: FDA K252007 describes cloud analysis of uploaded adult lung-ultrasound clips, including B-line artifact detection, for qualified users. It does not directly interface with scanners and its output must not alone determine patient management. The clearance therefore cannot be extended to offline ATLAS trauma claims.
Canadian footprint
Deep Breathe is based at 45 King Street, Suite 300, London, Ontario. Its enquiry route supports demonstrations, quotations and research collaborations.
London, Ontario is the published city-level context for Deep Breathe. It does not imply a street address or exact facility location.
Deep Breathe is a relevant evaluation partner for teams seeking ultrasound decision support in disconnected or resource-constrained settings. NATO DIANA provides an adoption pathway, while the FDA record supplies a precise boundary for the separately cleared BlineSlide product. Discussions should begin with the intended indication, user and evaluation protocol.
Interpretation of the public record. Not qualification, endorsement or evidence of buyer interest.
ATLAS is designed for AI-assisted point-of-care assessment of critical torso injuries using software running locally on iOS or Android with existing ultrasound hardware. Its clinical readiness must be distinguished from the separately cleared cloud-based BlineSlide device.
Evidence of maturity
ATLASim is offered for education and training. The company says broader ATLAS regulatory approvals are being pursued; BlineSlide's FDA clearance does not establish clearance of offline ATLAS trauma applications.
Commercial availability
ATLASim educational access is described as available. Diagnostic deployment requires confirmation of the specific product's regulatory scope and clinical validation.
Core features
Local iOS or Android processing without internet connectivity
Compatibility with existing ultrasound hardware
AI-assisted assessment of life-threatening torso injuries
Recorded applications
Assessment workflows in austere or disconnected medical settings
NATO DIANA selected Deep Breathe for its 15-company Mission Track cohort, announced September 2, 2026. The programme provides €300,000 of non-dilutive support, test-centre access and adoption assistance. This advances evaluation and adoption work; it is not a military procurement award or clinical approval.
Innovative Solutions Canada lists Deep Breathe Inc.'s ATLAS as an available-for-testing innovation in the military and space theme; the relationship is a public testing-stream listing and not a procurement outcome.
Reviewed connections
Mission area · Reviewed connectionEvidence strength: Moderate
On-device AI analysis without cloud dependence could support remote or disconnected diagnostic workflows; this is a derived mapping and is not evidence of a CAF deployment or clinical endorsement.
Reviewed connections indicate possible relevance based on public evidence. They do not indicate procurement direction, eligibility, endorsement or customer interest.
Questions for a first conversation
01
Which ATLAS version and indication are proposed for the evaluation, what regulatory status applies, and what evidence supports performance in the intended user and field setting?
Broader ATLAS regulatory approvals and deployment-specific clinical validation remain pending; inaccessible additional study text is not used to assert diagnostic accuracy.
Original sources 10 linked records
These records support the organization, its owned capabilities and their reviewed connections. A source count is not a count of independent confirmations.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Supports: Profile · operating context
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Supports: Profile · executive relevance summary
Source location: executiveRelevanceSummary
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Supports: ATLAS offline ultrasound assessment software · core features
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Supports: ATLAS offline ultrasound assessment software · capability type
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Supports: ATLAS offline ultrasound assessment software · core features
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Supports: ATLAS offline ultrasound assessment software · core features
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Supports: ATLAS offline ultrasound assessment software · name
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Supports: ATLAS offline ultrasound assessment software → Edge Data Processing
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Supports: ATLAS offline ultrasound assessment software → Edge Data Processing
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Supports: ATLAS offline ultrasound assessment software → Edge Data Processing
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Supports: ATLAS offline ultrasound assessment software → Edge Data Processing
ATLAS is designed for AI-assisted point-of-care assessment of life-threatening torso injuries. Deep Breathe describes software running locally on iOS or Android without internet connectivity and compatibility with existing ultrasound hardware. Platform-wide diagnostic performance is not established by this product description alone.
Innovative Solutions Canada lists Deep Breathe Inc.'s ATLAS as an available-for-testing innovation in the military and space theme; the relationship is a public testing-stream listing and not a procurement outcome.
Supports: Profile · current activity
Innovative Solutions Canada lists Deep Breathe's ATLAS as available for testing, and the company's current material describes local on-device operation for trauma diagnostics.
Deep Breathe appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.
Supports: Profile · current activity as of
Deep Breathe appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.
True North Map derives this first-conversation question from the documented Deep Breathe capability, current evidence and the decision gap that remains.
Deep Breathe's public evidence establishes its current role and offering, but it does not answer every access, configuration, eligibility, maturity or buyer question needed for a first business-development conversation.
Deep Breathe publishes 45 King Street, Suite 300, London, Ontario N6A 1B8 as headquarters and mailing address. Its contact form accepts demonstration, quotation and research-collaboration enquiries; the published fallback email is general@deepbreathe.ai.
Deep Breathe publishes 45 King Street, Suite 300, London, Ontario N6A 1B8 as headquarters and mailing address. Its contact form accepts demonstration, quotation and research-collaboration enquiries; the published fallback email is general@deepbreathe.ai.
Public sources cited · Facts and assessments kept separate · Human review
Innovative Solutions Canada lists Deep Breathe's ATLAS as available for testing, and the company's current material describes local on-device operation for trauma diagnostics.
Supports: Testing Stream innovator relationship
Source location: relationships.0.publicSummary
Innovative Solutions Canada lists Deep Breathe Inc.'s ATLAS as an available-for-testing innovation in the military and space theme; the relationship is a public testing-stream listing and not a procurement outcome.
Deep Breathe appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.
Deep Breathe appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.
Supports: Profile · executive relevance summary
Source location: executiveRelevanceSummary
Deep Breathe appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.
Deep Breathe appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.
Supports: Profile · current activity
Deep Breathe appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.
The official public contact pathway for Deep Breathe is https://deepbreathe.ai/.
Supports: Profile · canadian footprint
Deep Breathe has a documented Canadian operating presence in London, Ontario.
Supports: Profile · description
Deep Breathe is a London, Ontario medical-technology company developing locally run artificial-intelligence tools that use ultrasound to assist point-of-care diagnosis of serious lung and torso conditions.
Deep Breathe's ATLAS is a vendor-agnostic, on-device AI software system for portable ultrasound that is designed to assist trauma and CBRNE-related torso-injury assessment in connected or no-connectivity settings.
Supports: ATLAS offline ultrasound assessment software → Edge Data Processing
On-device AI analysis without cloud dependence could support remote or disconnected diagnostic workflows; this is a derived mapping and is not evidence of a CAF deployment or clinical endorsement.
Deep Breathe publishes 45 King Street, Suite 300, London, Ontario N6A 1B8 as headquarters and mailing address. Its contact form accepts demonstration, quotation and research-collaboration enquiries; the published fallback email is general@deepbreathe.ai.
Deep Breathe publishes 45 King Street, Suite 300, London, Ontario N6A 1B8 as headquarters and mailing address. Its contact form accepts demonstration, quotation and research-collaboration enquiries; the published fallback email is general@deepbreathe.ai.
Supports: Profile · canadian footprint
Deep Breathe publishes 45 King Street, Suite 300, London, Ontario N6A 1B8 as headquarters and mailing address. Its contact form accepts demonstration, quotation and research-collaboration enquiries; the published fallback email is general@deepbreathe.ai.
FDA cleared BlineSlide under K252007 on October 6, 2025. The summary describes cloud-based analysis of uploaded B-mode lung-ultrasound clips for adults, including a B-line artifact module, for qualified clinical users. It does not directly interface with scanners and patient management must not rely solely on its output. This scope differs from offline ATLAS field-use claims.
FDA cleared BlineSlide under K252007 on October 6, 2025. The summary describes cloud-based analysis of uploaded B-mode lung-ultrasound clips for adults, including a B-line artifact module, for qualified clinical users. It does not directly interface with scanners and patient management must not rely solely on its output. This scope differs from offline ATLAS field-use claims.
FDA cleared BlineSlide under K252007 on October 6, 2025. The summary describes cloud-based analysis of uploaded B-mode lung-ultrasound clips for adults, including a B-line artifact module, for qualified clinical users. It does not directly interface with scanners and patient management must not rely solely on its output. This scope differs from offline ATLAS field-use claims.
FDA cleared BlineSlide under K252007 on October 6, 2025. The summary describes cloud-based analysis of uploaded B-mode lung-ultrasound clips for adults, including a B-line artifact module, for qualified clinical users. It does not directly interface with scanners and patient management must not rely solely on its output. This scope differs from offline ATLAS field-use claims.
FDA cleared BlineSlide under K252007 on October 6, 2025. The summary describes cloud-based analysis of uploaded B-mode lung-ultrasound clips for adults, including a B-line artifact module, for qualified clinical users. It does not directly interface with scanners and patient management must not rely solely on its output. This scope differs from offline ATLAS field-use claims.
Supports: Profile · operating context
FDA cleared BlineSlide under K252007 on October 6, 2025. The summary describes cloud-based analysis of uploaded B-mode lung-ultrasound clips for adults, including a B-line artifact module, for qualified clinical users. It does not directly interface with scanners and patient management must not rely solely on its output. This scope differs from offline ATLAS field-use claims.
FDA cleared BlineSlide under K252007 on October 6, 2025. The summary describes cloud-based analysis of uploaded B-mode lung-ultrasound clips for adults, including a B-line artifact module, for qualified clinical users. It does not directly interface with scanners and patient management must not rely solely on its output. This scope differs from offline ATLAS field-use claims.
FDA cleared BlineSlide under K252007 on October 6, 2025. The summary describes cloud-based analysis of uploaded B-mode lung-ultrasound clips for adults, including a B-line artifact module, for qualified clinical users. It does not directly interface with scanners and patient management must not rely solely on its output. This scope differs from offline ATLAS field-use claims.
National Defence awarded Deep Breathe FCIA-DIANA funding for ATLAS, an on-edge multi-diagnostic AI system intended to support real-time detection of traumatic torso injuries.
Supports: Profile · current activity
National Defence records a CAD 169,000 FCIA-DIANA contribution to Deep Breathe Inc. for ATLAS.
Deep Breathe states that its B-line model has FDA 510(k) clearance, while approvals for broader ATLAS platforms are being pursued. It identifies ATLASim as available for education and training and describes military engagement in an educational and evaluation capacity.
Deep Breathe states that its B-line model has FDA 510(k) clearance, while approvals for broader ATLAS platforms are being pursued. It identifies ATLASim as available for education and training and describes military engagement in an educational and evaluation capacity.
Deep Breathe states that its B-line model has FDA 510(k) clearance, while approvals for broader ATLAS platforms are being pursued. It identifies ATLASim as available for education and training and describes military engagement in an educational and evaluation capacity.
Deep Breathe states that its B-line model has FDA 510(k) clearance, while approvals for broader ATLAS platforms are being pursued. It identifies ATLASim as available for education and training and describes military engagement in an educational and evaluation capacity.
Continue exploring
Follow the strongest connections
Continue through related organizations, reviewed mission and Defence need connections, programme pathways, and explicitly linked intelligence. Similarity results describe shared areas of work, not partnerships or endorsements.
Organizations
Profiles that provide the strongest reviewed or discovery-led continuation.
